Skip to main content
. 2005 Dec 21;11(47):7436–7443. doi: 10.3748/wjg.v11.i47.7436

Figure 6.

Figure 6

Incidence of intestinal metaplasia distant from the anastomosis site (A) and esophageal adenocarcinoma (B). The risk of both intestinal metaplasia and adenocarcinoma was significantly lower in the SOD-treated group than in the control group (P = 0.046 and P = 0.021, respectively) (n = 6-10).